Effects of MK-801 on nitrite and cGMP levels during focal cerebral ischemia in rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Nitric oxide

• Publication date

  2005-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NIOX.2005.07.005PMID 16122952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathology of cerebral ischaemia - mechanisms involved in neuronal damage

  2003cited by this paper
• The effects of NMDA receptor antagonist MK-801 on lipid peroxidation during focal cerebral ischemia in rats.

  2002cited by this paper
• Biochemical evidence of crossed cerebellar diaschisis in terms of nitric oxide indicators and lipid peroxidation products in rats during focal cerebral ischemia

  2001cited by this paper
• Free Radicals in Brain Pathophysiology

  2000cited by this paper
• Subacute But Not Acute Generation of Nitric Oxide in Focal Cerebral Ischemia

  2000cited by this paper
• Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia.

  2000cited by this paper
• Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion.

  2000cited by this paper
• Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury

  1999cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia.

  1998cited by this paper
• Free radicals, oxidative stress, and antioxidants : pathological and physiological significance

  1998cited by this paper
• Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia.

  1998cited by this paper
• The effects of nitric oxide synthase inhibitor, L-NAME on NO production during focal cerebral ischemia in rats: could L-NAME be the future treatment of sudden deafness?

  1997cited by this paper
• Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries.

  1997cited by this paper
• Dose‐ and time‐dependence of l‐NAME neuroprotection in transient focal cerebral ischaemia in rats

  1997cited by this paper
• Effects of Lamotrigine on brain nitrite and cGMP levels during focal cerebral ischemia in rats

  1997cited by this paper
• Inhibitory role of N omega-nitro-L-arginine methyl ester (L-NAME), a potent nitric oxide synthase inhibitor, on brain malondialdehyde and conjugated diene levels during focal cerebral ischemia in rats.

  1997cited by this paper
• Neuroprotective Actions of FK506 in Experimental Stroke: In Vivo Evidence against an Antiexcitotoxic Mechanism

  1997cited by this paper
• The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia.

  1996cited by this paper
• Characterization of l‐Arginine and Aminoguanidine Uptake into Isolated Rat Choroid Plexus: Differences in Uptake Mechanisms and Inhibition by Nitric Oxide Synthase Inhibitors

  1995cited by this paper
• Excitotoxicity and the NMDA receptor--still lethal after eight years.

  1995cited by this paper
• Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats.

  1995cited by this paper
• The Complex Role of Nitric Oxide in the Pathophysiology of Focal Cerebral Ischemia

  1994cited by this paper
• Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome.

  1994cited by this paper
• Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.

  1994cited by this paper
• Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome.

  1994cited by this paper
• Nitric Oxide Production During Focal Cerebral Ischemia in Rats

  1993cited by this paper
• Mechanisms Involved in the Neuroprotective Activity of a Nitric Oxide Synthase Inhibitor During Focal Cerebral Ischemia

  1993cited by this paper
• Hypoperfusion and Vasoreactivity in the Thalamus and Cerebellum After Stroke

  1993cited by this paper
• Effect of Nitric Oxide Synthase Inhibition on Cerebral Blood Flow and Injury Volume During Focal Ischemia in Cats

  1993cited by this paper
• Cerebellar diaschisis revisited

  1992cited by this paper
• Excitatory Amino Acid Receptors Coupled to the Nitric Oxide/Cyclic GMP Pathway in Rat Cerebellum During Development

  1991cited by this paper
• Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

  1991cited by this paper
• Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

  1990cited by this paper
• Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.

  1989cited by this paper
• NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices.

  1989cited by this paper
• Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.

  1989cited by this paper
• Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the Cat

  1988cited by this paper
• The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat

  1988cited by this paper
• Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil

  1987cited by this paper
• Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia.

  1987cited by this paper
• Glutamate and the pathophysiology of hypoxic–ischemic brain damage

  1986cited by this paper
• The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

  1986cited by this paper
• Fluorometric determination of nitrite with 4-hydroxycoumarin.

  1986cited by this paper
• NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones

  1986cited by this paper
• A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.

  1986cited by this paper
• Perinatal Hypoxia‐Ischemia Disrupts Striatal High‐Affinity [3H]Glutamate Uptake into Synaptosomes

  1986cited by this paper
• Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments

  1985cited by this paper
• Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.

  1985cited by this paper
• Cellular Origin of Ischemia‐Induced Glutamate Release from Brain Tissue In Vivo and In Vitro

  1985cited by this paper
• Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

  1984cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death

  1984cited by this paper
• Effects of Anoxia on the Stimulated Release of Amino Acid Neurotransmitters in the Cerebellum In Vitro

  1983cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Chronically Pre-treatment of Pistachio Alters the Morphology of CA1 Hippocampus Neurons Following Transient Focal Cerebral Ischemia in Male Wistar Rats

  2022cites this paper
• A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study

  2016cites this paper
• Neuroprotection by μ-calpain and matrix metalloproteinases inhibition by Piroxicam in cerebral ischemia: an in silico study

  2013cites this paper
• اثر محافظت نورونی هیستیدین بر سلول های ناحیه CA1 هیپوکامپ موش صحرایی متعاقب انسداد موقت شریان مغزی میانی

  2012cites this paper
• Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection.

  2012cites this paper
• Glutamate antagonism fails to reverse mitochondrial dysfunction in late phase of experimental neonatal asphyxia in rats.

  2011cites this paper
• The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia.

  2011cites this paper
• Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia.

  2011influential citation
• Neuroprotective effect of flurbiprofen in focal cerebral ischemia: the possible role of ASIC1a.

  2010cites this paper